ROYCE & ASSOCIATES LP - ABEONA THERAPEUTICS INC ownership

ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 57 filers reported holding ABEONA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ABEONA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$223,000
+53.8%
142,2210.0%0.00%0.0%
Q3 2020$145,000
-65.1%
142,2210.0%0.00%
-60.0%
Q2 2020$415,000
+38.8%
142,2210.0%0.01%
+25.0%
Q1 2020$299,000
-35.7%
142,2210.0%0.00%0.0%
Q4 2019$465,000
+44.9%
142,2210.0%0.00%
+33.3%
Q3 2019$321,000
-52.8%
142,2210.0%0.00%
-50.0%
Q2 2019$680,000
-35.1%
142,2210.0%0.01%
-33.3%
Q1 2019$1,047,000
+3.2%
142,2210.0%0.01%0.0%
Q4 2018$1,015,000
-44.2%
142,2210.0%0.01%
-30.8%
Q3 2018$1,820,000
-20.0%
142,2210.0%0.01%
-18.8%
Q2 2018$2,276,000
+11.5%
142,2210.0%0.02%
+14.3%
Q1 2018$2,041,000
-9.4%
142,2210.0%0.01%
-6.7%
Q4 2017$2,254,000
-41.8%
142,221
-37.4%
0.02%
-42.3%
Q3 2017$3,874,000
+93.9%
227,221
-27.2%
0.03%
+100.0%
Q2 2017$1,998,000
+28.0%
312,2210.0%0.01%
+30.0%
Q1 2017$1,561,000
+3.1%
312,2210.0%0.01%0.0%
Q4 2016$1,514,000
-32.7%
312,221
-16.7%
0.01%
-33.3%
Q3 2016$2,249,000
+153.3%
374,821
-0.4%
0.02%
+150.0%
Q2 2016$888,000
-7.8%
376,3210.0%0.01%0.0%
Q1 2016$963,000
-4.4%
376,321
+25.6%
0.01%0.0%
Q4 2015$1,007,000
+334.1%
299,643
+424.0%
0.01%
+500.0%
Q3 2015$232,00057,1810.00%
Other shareholders
ABEONA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,215,740$709,0000.44%
AIGH Capital Management LLC 5,025,100$1,583,0000.39%
Worth Venture Partners, LLC 1,244,774$392,0000.18%
Kore Private Wealth LLC 154,637$49,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 8,007,272$2,522,0000.01%
Point72 Asset Management, L.P. 3,200,000$1,008,0000.00%
Cedar Brook Financial Partners, LLC 55,000$17,0000.00%
WealthTrust Axiom LLC 19,000$5,0000.00%
Phoenix Holdings Ltd. 296,872$91,0000.00%
IFP Advisors, Inc 10,000$175,0000.00%
View complete list of ABEONA THERAPEUTICS INC shareholders